About THE BURLINGTON HC RESEARCH GROUP, INC.
The Burlington HC Research Group, Inc. focuses on developing BRG drugs that target drug-resistant cancers, aiming to kill nearly all tumor cells with a single exposure when combined with other anticancer agents.
Development of drugs targeting drug-resistant cancersCombination therapy with anticancer agents to enhance efficacy
Is this your company?
Claim THE BURLINGTON HC RESEARCH GROUP, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim THE BURLINGTON HC RESEARCH GROUP, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.